BTX-1188 / BioTheryX 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BTX-1188 / BioTheryX
NCT05144334: A Study of BTX-1188 in Subjects With Advanced Malignancies

Terminated
1
8
US
BTX-1188
BioTheryX, Inc.
Advanced Solid Tumor, Non Hodgkin Lymphoma, Acute Myeloid Leukemia
09/23
09/23

Download Options